Anlotinib combined with sintilimab as first-line treatment in patients with advanced non-clear cell renal cell carcinoma: Preliminary results from an exploratory prospective clinical study.

被引：0
|
作者：
Dong, Pei [1 ]
Wei, Wensu [1 ]
Jiang, Lijuan [1 ]
Zhang, Zhiling [1 ]
Guo, Shengjie [1 ]
Han, Hui [1 ]
Cai, Xiuyu [1 ]
Zhou, Fangjian [1 ]
机构：
[1] Sun Yat Sen Univ, Dept Urol, Canc Ctr, Guangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16546
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Sunitinib in advanced metastatic non-clear cell renal cell carcinoma: a single institution retrospective study
    Paglino, Chiara
    Imarisio, Ilaria
    Ganini, Carlo
    Morbini, Patrizia
    Vercelli, Alessandro
    Bregant, Cristina
    Porta, Camillo
    FUTURE ONCOLOGY, 2012, 8 (12) : 1605 - 1612
  • [42] First-line anlotinib-based combination treatment for patients with advanced non-small cell lung cancer: A threearm, prospective study
    Han, B.
    Chu, T.
    Zhang, W.
    Han, B.
    Zhang, X.
    Shi, C.
    Zhong, R.
    Zhong, H.
    Wang, W.
    Gu, A.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (04) : S789 - S789
  • [43] Clinical outcomes of first-line combination therapy with immune checkpoint inhibitor for metastatic non-clear cell renal cell carcinoma: a multi-institutional retrospective study in Japan
    Yoshimura, Akihiro
    Kato, Taigo
    Nakai, Yasutomo
    Tsujihata, Masao
    Toyoda, Shingo
    Sato, Mototaka
    Matsuzaki, Kyosuke
    Nakata, Wataru
    Takao, Tetsuya
    Inoguchi, Syunsuke
    Okuda, Yohei
    Yamamichi, Gaku
    Ishizuya, Yu
    Yamamoto, Yoshiyuki
    Hatano, Koji
    Kawashima, Atsunari
    Takada, Shingo
    Inoue, Hitoshi
    Nishimura, Kensaku
    Miyake, Osamu
    Fujita, Kazutoshi
    Nakayama, Masashi
    Nishimura, Kazuo
    Nonomura, Norio
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2024, 29 (12) : 1916 - 1924
  • [44] Efficacy and Safety of Sintilimab with Anlotinib as First-Line Therapy for Advanced Non-Small Cell Lung Cancer (NSCLC)
    Han, B.
    Chu, T.
    Zhong, R.
    Zhong, H.
    Zhang, B.
    Zhang, W.
    Shi, C.
    Qian, J.
    Han, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S129 - S129
  • [45] Successful apatinib treatment for advanced clear cell renal carcinoma as a first-line palliative treatment: A case report
    Hang-Ping Wei
    Jie Mao
    Zu-Liang Hu
    World Journal of Clinical Cases, 2022, 10 (11) : 3593 - 3600
  • [46] Atezolizumab plus bevacizumab in non-clear cell renal cell carcinoma (NccRCC) and clear cell renal cell carcinoma with sarcomatoid differentiation (ccRCCsd): Updated results of activity and predictive biomarkers from a phase II study.
    Flippot, Ronan
    McGregor, Bradley Alexander
    Flaifel, Abdallah
    Gray, Kathryn P.
    Signoretti, Sabina
    Steinharter, John A.
    Van Allen, Eliezer Mendel
    Walsh, Meghara K.
    Gundy, Katy
    Wei, Xiao X.
    Harshman, Lauren Christine
    Vaishampayan, Ulka N.
    Choueiri, Toni K.
    McKay, Rana R.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [47] Successful apatinib treatment for advanced clear cell renal carcinoma as a first-line palliative treatment: A case report
    Wei, Hang-Ping
    Mao, Jie
    Hu, Zu-Liang
    WORLD JOURNAL OF CLINICAL CASES, 2022, 10 (11) : 3593 - 3600
  • [48] Phase II KEYNOTE-B61 study of pembrolizumab (Pembro) plus lenvatinib (Lenva) as first-line treatment for non-clear cell renal cell carcinoma (nccRCC)
    Albiges, L.
    Gurney, H. P.
    Atduev, V.
    Suarez, C.
    Climent Duran, M. A.
    Pook, D.
    Tomczak, P.
    Barthelemy, P.
    Lee, J-L.
    Nalbandian, T.
    Stus, V.
    Ferguson, T.
    Wiechno, P.
    Gokmen, E.
    Lacombe, L.
    Gedye, C.
    Perini, R.
    Sharma, M.
    Li, C.
    Lee, C-H.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1204 - S1204
  • [49] Multicenter phase II study of sunitinib in patients with non-clear cell renal cell carcinoma
    Lee, J. -L.
    Ahn, J. -H.
    Lim, H. Y.
    Park, S. H.
    Lee, S. H.
    Kim, T. M.
    Lee, D. -H.
    Cho, Y. M.
    Song, C.
    Hong, J. H.
    Kim, C. -S.
    Ahn, H.
    ANNALS OF ONCOLOGY, 2012, 23 (08) : 2108 - 2114
  • [50] Non-interventional study on first-line therapy in advanced renal cell carcinoma
    Rexer, H.
    Merseburger, A.
    Doehn, C.
    UROLOGIE, 2023, 62 (02): : 220 - 221
12345